The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro

Maturitas

Volumn 25, Issue 2, 1996, Pages 125-131

  McManus, Joanne ^a,b   McEneny, Jane ^a   Young, Ian S ^a   Thompson, William ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Atherosclerosis; Lipid peroxidation; Oestrogens

Indexed keywords

EQUILIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; GESTAGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORGESTREL;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; OXIDATION;

EID: 0030271917     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01053-5     Document Type: Article

References (27)

1. [1] Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
2. [2] Hough JL, Zilversmit DB. Effect of 17-beta-estradiol on aortic cholesterol content and metabolism in cholesterolfed rabbits. Arteriosclerosis 1986; 6: 57-63.
3. [3] Adams MR, Kaplan JR, Manuck AB et al. Inhibition of coronary artery atherosclerosis by 17-beta-estradiol in ovariectomized monkeys. Arteriosclerosis 1990; 10: 1051-1057.
4. [4] Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861-1867.
5. [5] Samsoie G. Hormone replacement therapy and cardiovascular disease. Int J Fertil 1993; 38:(Suppl1) 23-29.
6. [6] Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
7. [7] Steinberg D, Parthasarathy S, Carew TE, Khoo JD and Witztum JL. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
8. [8] Steinberg D, Witzum JL. Lipoproteins and atherogenesis: current concepts. J Am Med Assoc 1990; 264: 3047-3052.
9. [9] Morrel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-364.
10. [10] Hessler JR, Robertson AL, Chisolm GL. LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979; 32: 213-219.
11. [11] Kugiyama K, Kerns SA, Morriset JD, Roberts R, Henry PD. Impairment of endothelial derived arterial relaxation by lysolethicin in modified low density lipoproteins. Nature 1990; 344: 160-162.
12. [12] Maziere C, Auclair M, Ronveaux M, Salmon S, Santus R and Maziere JC. Oestrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 1991; 89: 175-182.
13. [13] Ravi Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W and Rymaszewski Z. Antioxidant potential of specific oestrogens on lipid peroxidation. J Clin Endocrinol Metab 1993; 77: 1095-1097.
14. [14] Rifici VA and Khachadurian AK. The inhibition of low density lipoprotein oxidation by 17-β estradiol. Metabolism 1992; 41: 1110-1114.
15. [15] Huber LA, Scheffler E, Poll T, Ziegler R and Dresel HA. 17-beta-estradiol inhibits oxidation and cholesterol ester formation in cultured macrophages. Free Rad Res Comms 1990; 8: 167-173.
16. [16] Negre-Salvayre A, Pieraggi MT, Mabile L and Salvayre R. Protective effect of 17-β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993; 99: 207-217.
17. [17] Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-270.
18. [18] Mc Dowell IF, Mc Eneny J, Trimble ER. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995; 32: 167-174.
19. [19] Sattler W, Christison J, Stocker R. Cholesteryl ester hydroperoxide reducing activity associated with isolated high-and low-density lipoproteins. Free Rad Biol Med 1995; 18: 421-429.
20. [20] Jialal I, Grundy SM. Effect of dietary supplementation with alpha tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992; 33: 899-906.
21. [21] Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 1993; 49: 679-699.
22. [22] Guetta V, Panza JA, Waclawiw MA, Cannon RO. Effect of combined 17-β-estradiol and vitamin E on low density lipoprotein oxidation in postmenopausal women. Am J Cardiol 1995; 75, 1274-1276.
23. [23] Keaney JF, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17-β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolamic swine. Circulation 1994; 89: 2251-2259.
24. 2+-catalyzed oxidation of low or high density lipoprotein: Antioxidative effects of steroids on lipoproteins. Endocrine J 1994; 41: 605-611.
25. [25] Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 1995; 30: 141-146.
26. [26] Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 1993; 102: 63-67.
27. [27] Tomkin GH, Owens D. Anti-atherogenic action of oestrogen [letter]. Lancet 1994; 343: 598.